Get the Daily Brief
Latest Biotech News
Abivax Shows Additional Positive Data in Phase 3 Ulcerative Colitis Trial
Abivax presented further analyses from its pivotal Phase 3 trial of obefazimod, its lead drug candidate for ulcerative colitis. The pooled data from nearly 1,300 patients reinforce the therapeutic...
Sofinnova’s Strategic Rescue Sparks Abivax’s Phase III Triumph
Sofinnova Partners orchestrated a transformative comeback for French biotech Abivax, beginning with a pivotal €12 million investment in 2019 during the company's financial distress. Recognizing...
AstraZeneca Advances Hypertension and Breast Cancer Treatments
AstraZeneca reported victories on multiple fronts with its blood pressure drug baxdrostat, securing a second successful Phase 3 trial demonstrating efficacy in treatment-resistant hypertension...
Skye Bioscience’s Obesity Drug Stumbles in Phase 2 Trial
Skye Bioscience faced a major setback when its CB1 receptor-blocking antibody nimacimab failed to achieve significant weight loss as monotherapy in a 26-week Phase 2a trial. Despite this,...
AI-Driven Drug Discovery and Biotech Investment Trends Intensify
Artificial intelligence continues to reshape biotech discovery and investment landscapes. Insilico Medicine unveiled its LEGION workflow to comprehensively explore drug-like chemical space while...
Regulatory and Manufacturing Shifts Propel Biopharma Ecosystem Changes
Recent regulatory and manufacturing initiatives signal a pivotal shift in biopharmaceutical industry operations. The FDA launched a pilot program to accelerate generic drug approvals emphasizing...
Nobel Prize Honors Regulatory T Cell Discoveries in Autoimmunity
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for elucidating regulatory T cells (Tregs), a crucial peripheral immune tolerance...
Novel Nanoparticle Therapy Reverses Alzheimer’s Pathology in Mice
Researchers at the Institute for Bioengineering of Catalonia and West China Hospital introduced a bioactive nanoparticle therapy that restores blood-brain barrier function, enabling efficient...
Lund University Antibody Restores Immune Attack on Leukemia Cells
Lund University researchers uncovered that acute myeloid leukemia (AML) cells express SLAMF6, an immune checkpoint protein enabling escape from T cell-mediated destruction. By engineering an...
Breakthroughs in Genetic and Molecular Oncology Diagnostics
Cutting-edge AI, genomic, and molecular diagnostic advances are reshaping cancer care. Transformer models combined with radiomic data now predict cervical cancer prognosis with enhanced accuracy....
Advances in RNAi Therapeutics and RNA Modifications in Cancer and Metabolism
Aerska, a biotech focusing on RNA interference, raised $21 million to develop antibody-oligo conjugates for delivering RNAi drugs across the blood-brain barrier targeting neurological diseases...
AstraZeneca and Algen Biotechnologies Join Forces on $555M AI Drug Discovery Pact
AstraZeneca has inked a $555 million agreement with San Francisco-based Algen Biotechnologies to harness Algen's AI-driven AlgenBrain platform targeting immunology drug discovery. The partnership...
Skye Bioscience's Obesity Drug Fails Phase 2, Combination Therapy Shows Promise
Skye Bioscience reported that its CB1 receptor inhibitor, nimacimab, did not achieve statistically significant weight loss in a mid-stage Phase 2a trial when used as monotherapy. The antibody...
Nobel Prize Honors Discoveries in Regulatory T Cells on Immune Tolerance
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for seminal discoveries concerning regulatory T cells (Tregs) and their role in...
New Nanoparticle Therapy Reverses Alzheimer's in Mice by Restoring Blood-Brain Barrier
Researchers at the Institute for Bioengineering of Catalonia and West China Hospital Sichuan University have developed a bioactive nanoparticle therapy that reverses Alzheimer’s disease pathology...
Lund University Uncovers Leukemia Immune Escape Mechanism Targeted by Antibody
Lund University researchers have identified the SLAMF6 surface protein as an immune checkpoint mediating acute myeloid leukemia's (AML) evasion from immune attack. SLAMF6, expressed on AML stem...
International Clinical Trial Advances Prostate Cancer Treatment with Drug Combination
An international clinical trial led by University College London demonstrated that combining niraparib, a PARP inhibitor, with standard hormone therapies (abiraterone acetate and prednisone)...
FDA Initiates Pilot Program to Accelerate Generic Drug Approvals Using Domestic Sources
The US Food and Drug Administration announced a pilot program accelerating regulatory review for generic drugs manufactured domestically using US-sourced active pharmaceutical ingredients. This...
Asimov Commercializes Stable HEK293 Producer Cell Lines for Scalable AAV Gene Therapy Manufacturing
Asimov has launched its AAV Edge Stable Producer system, delivering clonal HEK293 stable cell lines that harbor essential viral genes for adeno-associated virus (AAV) vector manufacturing. These...
Insight Into Autoimmune Mechanisms in ALS Identifies Therapy Targets
New research published in Nature provides the first direct evidence of autoimmunity involvement in amyotrophic lateral sclerosis (ALS). Scientists discovered that CD4+ T helper cells in ALS...